Grace Therapeutics, Inc
GRCE3.400USD
+0.050+1.49%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
48.04MMarket Cap
LossP/E TTM
Grace Therapeutics, Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.79
41.31%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.792, with a year-on-year change of 41.31%.
What is the net income of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its net income was -9.57M, with a year-on-year change of 25.56%.
What is the net margin of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its Return on Equity (ROE) was -14.91%, with a year-on-year change of 24.78%.
What is the Return on Assets (ROA) of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its Return on Assets (ROA) was -13.17%, with a year-on-year change of 21.91%.
What is the operating profit of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its operating profit was -16.68M, with a year-on-year change of -46.73%.
What are the current assets of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its current assets were 22.71M, with a year-on-year change of -5.41%.
What are the total assets of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its total assets of Grace Therapeutics, Inc were 71.99M, with a year-on-year change of -1.78%.
What are the total liabilities of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its total liabilities of Grace Therapeutics, Inc were 5.38M, with a year-on-year change of -53.42%.
What is the total equity of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its total equity of Grace Therapeutics, Inc was 66.61M, with a year-on-year change of 7.88%.
What is the net operating income of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its net operating income of Grace Therapeutics, Inc was -9.57M, with a year-on-year change of 25.56%.
What is the net investment of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its net investment of Grace Therapeutics, Inc was --, with a year-on-year change of -100.00%.
What is the net financing of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2025 earnings report, its net financing of Grace Therapeutics, Inc was 14.03M, with a year-on-year change of 90.68%.
